Healthcare Analysts discuss emerging treatment options for High-Rick Non-Muscle Invasive Bladder Cancer (NMIBC) (relevant companies ENGN CGON JNJ IBRX TARA) on an Analyst/Industry conference call to be held on September 10.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN: